Mycobutin and Drowsiness - a phase IV clinical study of FDA data

Summary:

Drowsiness is reported as a side effect among people who take Mycobutin (rifabutin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Vitamin D, and have Arrhythmias.

The phase IV clinical study analyzes which people have Drowsiness when taking Mycobutin. It is created by eHealthMe based on reports of 831 people who have side effects when taking Mycobutin from the FDA, and is updated regularly.

What is Mycobutin?

Mycobutin has active ingredients of rifabutin. eHealthMe is studying from 843 Mycobutin users. Check the latest studies of Mycobutin.

What is Drowsiness?

Drowsiness is found to be associated with 2,864 drugs and 4,797 conditions by eHealthMe. Check the latest studies of Drowsiness.

On Jul, 19, 2026

831 people reported to have side effects when taking Mycobutin.
Among them, 12 people (1.44%) have Drowsiness.

Among these 12 people:

How long have people been on Mycobutin when they have Drowsiness? *

What is the gender of people who have Drowsiness when taking Mycobutin? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Drowsiness when taking Mycobutin? *

What are other drugs people take besides Mycobutin? *

What are other side effects people have besides Drowsiness? *

Headache (pain in head): 9 people, 75.00%
Nausea (feeling of having an urge to vomit): 7 people, 58.33%
Dizziness: 7 people, 58.33%
Pain: 7 people, 58.33%
Fatigue (feeling of tiredness): 6 people, 50.00%
Neuralgia (pain in one or more nerves): 5 people, 41.67%
Renal Pain (kidney pain): 5 people, 41.67%
Blood Creatinine Abnormal: 5 people, 41.67%
Muscle Aches (muscle pain): 5 people, 41.67%
Weakness: 5 people, 41.67%

What are the existing conditions these people have? *

Viral Infection: 2 people, 16.67%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 16.67%
Pulmonary Oedema (fluid accumulation in the lungs): 2 people, 16.67%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 16.67%
Osteoporosis (bones weak and more likely to break): 2 people, 16.67%
High Blood Cholesterol: 2 people, 16.67%
Helicobacter Gastritis (inflammation of the inner lining of the stomach caused by helicobacter pylori (h. pylori) a bacterium): 2 people, 16.67%
Arrhythmias (irregular heartbeat): 2 people, 16.67%
Pulmonary Tuberculosis (lungs tuberculosis): 1 person, 8.33%
Fluid Retention (an abnormal accumulation of fluid in the blood): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Mycobutin and have Drowsiness?

- Check whether Drowsiness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mycobutin:

Mycobutin (843 reports)

Drowsiness treatments and more:

Drowsiness (269,040 reports)

Browse all side effects of Mycobutin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Drowsiness:

Drowsiness (2,864 drugs)

Browse all the conditions that are associated with Drowsiness:

Drowsiness (4,797 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rifabutin (the active ingredients of Mycobutin) and Mycobutin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.